GB9116113D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9116113D0
GB9116113D0 GB919116113A GB9116113A GB9116113D0 GB 9116113 D0 GB9116113 D0 GB 9116113D0 GB 919116113 A GB919116113 A GB 919116113A GB 9116113 A GB9116113 A GB 9116113A GB 9116113 D0 GB9116113 D0 GB 9116113D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919116113A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GB919116113A priority Critical patent/GB9116113D0/en
Publication of GB9116113D0 publication Critical patent/GB9116113D0/en
Priority to PCT/GB1992/001366 priority patent/WO1993002078A1/en
Priority to JP5502709A priority patent/JPH06509337A/ja
Priority to CA002112561A priority patent/CA2112561A1/en
Priority to EP92916391A priority patent/EP0595980A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB919116113A 1991-07-25 1991-07-25 Therapeutic agents Pending GB9116113D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB919116113A GB9116113D0 (en) 1991-07-25 1991-07-25 Therapeutic agents
PCT/GB1992/001366 WO1993002078A1 (en) 1991-07-25 1992-07-23 Benzodiazepine derivatives, compositions containing them and their use in therapy
JP5502709A JPH06509337A (ja) 1991-07-25 1992-07-23 ベンゾジアゼピン誘導体、それらを含有する組成物及び治療におけるそれらの使用
CA002112561A CA2112561A1 (en) 1991-07-25 1992-07-23 Benzodiazepine derivatives, compositions containing them and their use in therapy
EP92916391A EP0595980A1 (de) 1991-07-25 1992-07-23 Benzodiazepinderivate, diese enthaltende zusammensetzungen und ihre verwendung in der heilkunde

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116113A GB9116113D0 (en) 1991-07-25 1991-07-25 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9116113D0 true GB9116113D0 (en) 1991-09-11

Family

ID=10698996

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919116113A Pending GB9116113D0 (en) 1991-07-25 1991-07-25 Therapeutic agents

Country Status (5)

Country Link
EP (1) EP0595980A1 (de)
JP (1) JPH06509337A (de)
CA (1) CA2112561A1 (de)
GB (1) GB9116113D0 (de)
WO (1) WO1993002078A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282595A (en) * 1993-08-25 1995-04-12 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
US5426185A (en) * 1993-11-22 1995-06-20 Merck & Co., Inc. Antiarrhythmic benzodiazepines
US5438055A (en) * 1993-11-22 1995-08-01 Merck & Co., Inc. Antiarrhythmic benzodiazepines
US5428157A (en) * 1993-11-22 1995-06-27 Merck & Co., Inc. 3-acylaminobenzodiazepines
JP2000504306A (ja) * 1994-08-18 2000-04-11 メルク エンド カンパニー インコーポレーテッド Ｎ―２，３―ジヒドロ―１―（２―プロピル）―２―オキソ―５―フェニル―１ｈ―１，４―ベンゾジアゼピン
KR970705395A (ko) * 1994-08-18 1997-10-09 폴락 도나 엘. 2,3-디하이드로-1-(2,2,2-트리플루오로에틸)-2-옥소-5-페닐-1H-1,4-벤조디아제핀(2,3-Dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1H-1,4-benzodiazepines)
US5556969A (en) * 1994-12-07 1996-09-17 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives
WO1996040656A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
WO2010022011A1 (en) * 2008-08-18 2010-02-25 The Gillette Company Combination shaving and trimming device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39413A0 (en) * 1971-05-13 1972-07-26 Sparamedica Ag Benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs

Also Published As

Publication number Publication date
EP0595980A1 (de) 1994-05-11
WO1993002078A1 (en) 1993-02-04
JPH06509337A (ja) 1994-10-20
CA2112561A1 (en) 1993-02-04

Similar Documents

Publication Publication Date Title
GB9121028D0 (en) Therapeutic agents
GB9119704D0 (en) Therapeutic agents
GB9103454D0 (en) Therapeutic agents
GB9117852D0 (en) Therapeutic agents
GB9116113D0 (en) Therapeutic agents
GB9104136D0 (en) Therapeutic agents
GB9111376D0 (en) Therapeutic agents
GB9116241D0 (en) Therapeutic agents
EG19704A (en) Therapeutic agents
GB9115017D0 (en) Therapeutic agents
GB9114551D0 (en) Therapeutic agents
GB9122305D0 (en) Therapeutic agents
GB9121968D0 (en) Therapeutic agents
GB9114288D0 (en) Therapeutic agents
GB9121527D0 (en) Therapeutic agents
GB9107403D0 (en) Therapeutic agents
GB9107438D0 (en) Therapeutic agents
GB9113892D0 (en) Therapeutic agents
GB9107439D0 (en) Therapeutic agents
GB9116767D0 (en) Therapeutic agents
GB9109974D0 (en) Therapeutic agents
GB9116238D0 (en) Therapeutic agents
GB9116175D0 (en) Therapeutic agents
GB9114312D0 (en) Therapeutic agents
GB9109816D0 (en) Therapeutic agents